ArticleCell death and differentiation2017

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

A Tosco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.